share on google plus
Text size
view with small font size
view with medium font size
view with large font size


REGPARA® is a new class of agent for the treatment of secondary hyperparathyroidism. REGPARA® acts on parathyroid calcium receptor directly and suppresses parathyroid hormone secretion, while simultaneously lowering serum calcium and phosphorus levels.

Product Image

Marketed by Kyowa Hakko Kirin in

Worldwide Locations

To Page Top